Sanofi-aventis has received approval for Apidra (insulinglulisine [rDNA origin] injection) to improve glycemic control in children agedfour years and older with diabetes mellitus. The clearance for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results